Literature DB >> 23276489

Giant SEPs and SEP-recovery function in Unverricht-Lundborg disease.

E Visani1, L Canafoglia, D Rossi Sebastiano, P Agazzi, F Panzica, V Scaioli, C Ciano, S Franceschetti.   

Abstract

OBJECTIVE: To evaluate the relationship between sensory hyperexcitability as revealed by giant SEPs and the SEP recovery function (SEP-R) in a series of patient with progressive myoclonic epilepsy of Unverricht-Lundborg type, identified as epilepsy, progressive myoclonic 1A (EPM1A), MIM #254800.
METHODS: We evaluated SEPs by applying median nerve stimuli and SEP-R using paired stimuli at inter-stimulus intervals (ISIs) of between 20 and 600 ms in 25 patients and 20 controls. The SEPs were considered "giant" if the N20P25 and P25N33 amplitudes exceeded normal mean values by +3SD.
RESULTS: During the paired-stimulus protocol, the SEPs elicited by the second stimulus (S2) were detectable at all ISIs but consistently suppressed in the 13 patients with giant SEPs reflecting a significantly delayed SEP-R. Maximal suppression roughly corresponded to the plateau of a broad middle latency (>100 ms) wave pertaining to the S1 response.
CONCLUSIONS: The cortical processing dysfunction generating giant SEPs in EPM1A patients consistently combines with a long-lasting suppression of hyperexcitability that leads to a delayed giant SEP-R without obstructing the response to incoming stimuli. SIGNIFICANCE: The delayed SEP-R is not due to true inhibition but the suppression of aberrant hyper-synchronisation sustaining giant SEPs. A broad middle latency SEP component adds a significantly suppressive effect. This suggests that cortico-subcortical circuitries contribute to both the gigantism and the delayed SEP-R.
Copyright © 2012 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23276489     DOI: 10.1016/j.clinph.2012.11.011

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  4 in total

1.  ANO10 mutational screening in recessive ataxia: genetic findings and refinement of the clinical phenotype.

Authors:  Lorenzo Nanetti; Elisa Sarto; Anna Castaldo; Stefania Magri; Alessia Mongelli; Davide Rossi Sebastiano; Laura Canafoglia; Marina Grisoli; Chiara Malaguti; Francesca Rivieri; Maria Chiara D'Amico; Daniela Di Bella; Silvana Franceschetti; Caterina Mariotti; Franco Taroni
Journal:  J Neurol       Date:  2018-12-04       Impact factor: 4.849

2.  Progressive myoclonic epilepsy type 1: Report of an Emirati family and literature review.

Authors:  Mohammed Saadah; Mahfoud El Beshari; Loai Saadah; Hisham Hamdallah; Zeinab Alloub; Amani Ali Al Zaabi; Abdelmatlob Ben-Mussa; Anwaar Ben-Nour
Journal:  Epilepsy Behav Case Rep       Date:  2014-05-04

3.  Unilateral Transient Enhanced SEP during Integrated Multiparameter Neurophysiological Monitoring in a Newborn with Symptomatic Seizure.

Authors:  Sara Cavaliere; Silvia Lori; Maria Bastianelli; Cesarina Cossu; Simonetta Gabbanini; Carlo Dani; Giovanna Bertini
Journal:  Pediatr Rep       Date:  2022-05-27

4.  The Effect of Insomnia on Cortical Excitability in Patients With Generalized Anxiety Disorder.

Authors:  Zhaoyang Huang; Shuqin Zhan; Chao Chen; Ning Li; Yan Ding; Yue Hou; Li Wang; Yuping Wang
Journal:  Front Psychiatry       Date:  2019-01-10       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.